Exploration Capital, LLC, 10% Owner at Fresh Tracks Therapeutics, Inc. (FRTX), bought 320 shares at $0.89 ($285) on 2024-05-06, disclosed to the SEC on 2024-05-08.
Open-market purchase of $285 FRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| FRTX | BUY | 2024-05-23 | $21K | — | Filing → |
| FRTX | BUY | 2024-05-20 | $136K | — | Filing → |
| FRTX | BUY | 2024-05-03 | $301K | — | Filing → |